CAR-NK cells in combination therapy against cancer: A potential paradigm
Open Access
Abstract
No abstract availableKeywords
Funding Information
- Hubei University of Medicine (XYY2023D02, XYY2023QT01)
This publication has 132 references indexed in Scilit:
- A Bio‐Liposome Activating Natural Killer Cell by Illuminating Tumor Homogenization Antigen PropertiesAdvanced Science, 2023
- Temperature‐Feedback Nanoplatform for NIR‐II Penta‐Modal Imaging‐Guided Synergistic Photothermal Therapy and CAR‐NK Immunotherapy of Lung CancerSmall, 2021
- Lenalidomide enhances the efficacy of anti-BCMA CAR-T treatment in relapsed/refractory multiple myeloma: a case report and revies of the literatureCancer Immunology, Immunotherapy, 2021
- Chimäre Antigenrezeptoren (CARs) in der Onkologie: eine Übersicht zu klinischer Anwendung und neuen EntwicklungenBundesgesundheitsblatt - Gesundheitsforschung - Gesundheitsschutz, 2020
- Chimeric antigen receptor therapy in hematological malignancies: antigenic targets and their clinical research progressAnnals of Hematology, 2020
- Use of CAR-T cell therapy, PD-1 blockade, and their combination for the treatment of hematological malignanciesClinical Immunology, 2020
- CAR-NK for tumor immunotherapy: Clinical transformation and future prospectsCancer Letters, 2020
- Outcomes of patients with large B‐cell lymphomas and progressive disease following CD19‐specific CAR T‐cell therapyAmerican Journal of Hematology, 2019
- Immune Checkpoint Inhibition Overcomes ADCP-Induced Immunosuppression by MacrophagesCell, 2018
- Development of NKG2D-based chimeric antigen receptor-T cells for gastric cancer treatmentCancer Chemotherapy and Pharmacology, 2018